Skip to main content
Literatur
1.
Zurück zum Zitat Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889–934.CrossRef Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol. 2014;63(25 Pt B):2889–934.CrossRef
2.
Zurück zum Zitat Sattar N, Taskinen MR. Statins are diabetogenic–myth or reality? Atheroscler Suppl. 2012;13(1):1–10.CrossRef Sattar N, Taskinen MR. Statins are diabetogenic–myth or reality? Atheroscler Suppl. 2012;13(1):1–10.CrossRef
3.
Zurück zum Zitat Betteridge DJ, Carmena R. The diabetogenic action of statins - mechanisms and clinical implications. Nat Rev Endocrinol. 2016;12(2):99–110.CrossRef Betteridge DJ, Carmena R. The diabetogenic action of statins - mechanisms and clinical implications. Nat Rev Endocrinol. 2016;12(2):99–110.CrossRef
4.
Zurück zum Zitat Navarese EP, Buffon A, Andreotti F, Kozinski M, Welton N, Fabiszak T, et al. Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus. Am J Cardiol. 2013;111(8):1123–30.CrossRef Navarese EP, Buffon A, Andreotti F, Kozinski M, Welton N, Fabiszak T, et al. Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus. Am J Cardiol. 2013;111(8):1123–30.CrossRef
5.
Zurück zum Zitat Zhang J, Shao Y, Liu Y, Tao J. A multi-center, open-label, two-arm parallel group non-inferiority randomized controlled trial evaluating the effect of pitavastatin, compared to atorvastatin, on glucose metabolism in prediabetics with hypertension and dyslipidemia: rationale and design for the China hemoglobin A1c metabolism protection union study (CAMPUS). Cardiovasc Drugs Ther. 2018;32(6):581–9.CrossRef Zhang J, Shao Y, Liu Y, Tao J. A multi-center, open-label, two-arm parallel group non-inferiority randomized controlled trial evaluating the effect of pitavastatin, compared to atorvastatin, on glucose metabolism in prediabetics with hypertension and dyslipidemia: rationale and design for the China hemoglobin A1c metabolism protection union study (CAMPUS). Cardiovasc Drugs Ther. 2018;32(6):581–9.CrossRef
6.
Zurück zum Zitat Prevention or delay of type 2 diabetes: standards of medical care in diabetes—2019. Diabetes Care. 2019;42(Supplement 1):S29–S33. Prevention or delay of type 2 diabetes: standards of medical care in diabetes—2019. Diabetes Care. 2019;42(Supplement 1):S29–S33.
7.
Zurück zum Zitat Zhao W, Zhao SP. Different effects of statins on induction of diabetes mellitus: an experimental study. Drug Des Devel Ther. 2015;9:6211–23.CrossRef Zhao W, Zhao SP. Different effects of statins on induction of diabetes mellitus: an experimental study. Drug Des Devel Ther. 2015;9:6211–23.CrossRef
8.
Zurück zum Zitat Nakagomi A, Shibui T, Kohashi K, Kosugi M, Kusama Y, Atarashi H, et al. Differential effects of atorvastatin and pitavastatin on inflammation, insulin resistance, and the carotid intima-media thickness in patients with dyslipidemia. J Atheroscler Thromb. 2015;22(11):1158–71.CrossRef Nakagomi A, Shibui T, Kohashi K, Kosugi M, Kusama Y, Atarashi H, et al. Differential effects of atorvastatin and pitavastatin on inflammation, insulin resistance, and the carotid intima-media thickness in patients with dyslipidemia. J Atheroscler Thromb. 2015;22(11):1158–71.CrossRef
Metadaten
Titel
Response Letter to Letter by Venu Jonnalagadda
verfasst von
Jun Tao
Publikationsdatum
08.08.2019
Verlag
Springer US
Erschienen in
Cardiovascular Drugs and Therapy / Ausgabe 6/2019
Print ISSN: 0920-3206
Elektronische ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-019-06897-7

Weitere Artikel der Ausgabe 6/2019

Cardiovascular Drugs and Therapy 6/2019 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.